Collection: Erythropoietin (EPO)

Erythropoietin (EPO) glycopeptides are specific peptide fragments derived from the EPO protein, a crucial hormone for regulating red blood cell production. In medical treatment, EPO glycopeptides are used in the development of therapeutic EPO formulations to treat anemia, particularly in patients with chronic kidney disease or undergoing chemotherapy. They are also employed in diagnostic assays to measure EPO levels in blood samples, which is vital for diagnosing and monitoring anemia and other erythropoiesis-related conditions. In biotechnology, EPO glycopeptides serve as tools for designing and improving EPO-based drugs by optimizing glycosylation patterns to enhance drug efficacy and reduce side effects. Additionally, research into EPO glycopeptides helps scientists understand the mechanisms of erythropoiesis and develop new treatments for blood disorders.